Cocktail of Popular Drugs May Cloud Brain - The New York Times.The Anticholinergic Cognitive Burden
Looking for:
- Site Search Navigation |
-
The greatest effect on cognitive decline was seen in the group with baseline MMSE scores of 26 to In this group, taking any definite anticholinergic medication was associated with a decline of an additional 0. Based on these findings, older patients who already have some degree of cognitive impairment would be considered most vulnerable to anticholinergic agents.
In advanced age, the central nervous system is very sensitive to adverse anticholinergic effects due to the significant decrease in cholinergic neurons or receptors in the brain, the reduction in hepatic metabolism and renal excretion of medications, and the increase in blood—brain barrier permeability. One unique and rather unanticipated aspect of the study is the link between mortality and anticholinergic burden. As with cognitive impairment, the association between the use of anticholinergic medication and death at 2 years was an observed dose-response effect involving the ACB score.
Moreover, the effect was present for the use of definite as well as possible anticholinergics, and results did not vary according to baseline MMSE scores.
In speculating on the reasons for the substantial increased risk of death observed among anticholinergic users, researchers appeared dissuaded from the idea that the studied population might have just been older or sicker at baseline. Data were adjusted for age, sex, baseline MMSE score, education, social class, number of nonanticholinergic medications, and number of health conditions. Although the lead author implicated the toll of anticholinergic agents on the cardiovascular and other major organ systems as a suspected reason for the increased risk of death, a cause-and-effect relationship has not been established.
In fact, researchers remain uncertain about the validity of the findings because medications with possible anticholinergic effects are used for many diseases eg, hypertension, congestive heart failure ; therefore, the results may, after all, reflect the prevalence of anticholinergic prescribing in disease states with significant morbidity.
Delirium was frequently identified by disorientation, altered consciousness, disorganized thinking, and fluctuating alertness. In applying the significance of these observations to the clinical setting, many practitioners rely on global measures to evaluate cognitive performance and, therefore, may not accurately identify a decline in cognitive function when evaluating exposure to anticholinergics. As previously mentioned, first-generation antihistamines are more easily identified as anticholinergic offenders, but other agents with anticholinergic properties such as digoxin, warfarin, prednisone, and codeine are unlikely to set off alarms among prescribers, or perhaps even among pharmacists.
Consumers may be better prepared to assess their own risk, given articles in the lay press, including the editorial in The New York Times, that refer them to the ACB scale. Abstract Corticosteroids are often used in combination with beta2-agonist and anticholinergic bronchodilators in the treatment of chronic obstructive pulmonary disease COPD. Publication types Research Support, Non-U. Gov't Review. Of the 36 million Americans 65 and older, at least 20 percent take at least one anticholinergic medication.
A study by Dr. Boustani of nearly 4, older adults in Indianapolis found that those who had been using three or more possibly anticholinergic drugs consistently for 90 days or longer were nearly three times as likely to receive a diagnosis of mild cognitive impairment as those who had not taken anticholinergics.
Boustani said. No association was found between chronic use of anticholinergics and dementia, however, even though mild cognitive impairment often precedes dementia. Boustani said the reasons for this were not clear. The aim of studies like these is to evaluate the magnitude of the effects of different drugs, to determine whether there are safe thresholds for their use and to learn whether the effect is transient and reversible.
Still, there is already a consensus in the scientific community that anticholinergic compounds should be prescribed with caution, especially for the elderly.
Still, Dr. Even so, why do physicians prescribe any medications with anticholinergic activity to elderly people, who may be using them regularly for many years? Not only are doctors often unaware of all the medicines their patients are taking, but the list of drugs with anticholinergic properties is a long one. The heart drug digoxin, the blood thinner warfarin, the painkiller codeine and prednisone are considered mild anticholinergics.
Those with the most severe effects include Paxil, Benadryl, a drug for overactive bladder called oxybutynin, and the schizophrenia drug clozapine. Fox said.
❿.
Is prednisone an anticholinergic drug.Cocktail of Popular Drugs May Cloud Brain
The heart drug digoxin, the blood thinner warfarin, the painkiller codeine and prednisone are considered mild anticholinergics. Those with the most severe effects include Paxil, Benadryl, a drug for overactive bladder called oxybutynin, and the schizophrenia drug clozapine.
Fox said. If you or an elderly relative take one or more drugs on a regular basis, ask your primary care physician to evaluate the cumulative anticholinergic burden of all them as well as other potential interactions and side effects.
Thies said. Remember to tell your physician about drugs prescribed by other specialists, as well as nonprescription or alternative medicines you take. He or she should be able to prescribe substitutes without anticholinergic effects.
This review should be done once a year. Do not stop medications on your own without medical supervision. Even before going to the doctor, do your own research. Use the Anticholinergic Burden scale , developed by scientists from the Regenstrief Institute, to assess your risk.
The scale ranks drugs based on the strength of their anticholinergic activity, from zero if there is no effect to 3 for severe effect. Keep in mind that many over-the-counter drugs, including allergy medications, antihistamines and Tylenol PM, have anticholinergic effects. Boustani advised. Delirium was frequently identified by disorientation, altered consciousness, disorganized thinking, and fluctuating alertness. In applying the significance of these observations to the clinical setting, many practitioners rely on global measures to evaluate cognitive performance and, therefore, may not accurately identify a decline in cognitive function when evaluating exposure to anticholinergics.
As previously mentioned, first-generation antihistamines are more easily identified as anticholinergic offenders, but other agents with anticholinergic properties such as digoxin, warfarin, prednisone, and codeine are unlikely to set off alarms among prescribers, or perhaps even among pharmacists. Consumers may be better prepared to assess their own risk, given articles in the lay press, including the editorial in The New York Times, that refer them to the ACB scale.
Rabin RC. Cocktail of popular drugs may cloud brain. Accessed February 29, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. Tune LE. Anticholinergic effects of medications in elderly patients. J Clin Psychiatry. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol.
Reinber S. Complementary interactions between corticosteroids and long-acting beta2-agonists and between corticosteroids and anticholinergic bronchodilators may be important if these drugs are combined in the treatment of COPD. Abstract Corticosteroids are often used in combination with beta2-agonist and anticholinergic bronchodilators in the treatment of chronic obstructive pulmonary disease COPD. Publication types Research Support, Non-U.
All rights reserved. Drugs with anticholingeric properties have been linked with clouded cognition and even increased mortality.
With the impending allergy season once again threatening to ruin spring, patients and health care providers share the common goal of containing the well-known allergic symptoms that appear to bloom right along with many of the offending flowering plants. Systemic antihistamines represent a major pharmacotherapy component in the management of seasonal allergies, so a discussion of recent renewed concerns over the anticholinergic effects of various medication classes—most relevantly antihistamine products—appears timely.
Among the drugs listed on the ACB scale as having definite anticholinergic effects are various first-generation antihistamines eg, diphenhydramine, brompheniramine, chlorpheniramine that are still widely used as either stand-alone products or as components in multi-ingredient cold and allergy preparations. Although the classic prototype antihistamine diphenhydramine remains widely used for extensive allergic symptoms particularly at nightthese latest findings may be viewed as yet another incentive to reserve potent first-generation antihistamines for more severe allergic symptoms, and for more occasional, rather than regular, use.
In the highlighted study, researchers followed approximately 13, British men and women 65 years or older with normal or mildly impaired cognition for 2 years. The greatest effect on cognitive decline was seen in the group with baseline MMSE scores of 26 to In this group, taking any definite anticholinergic medication was associated with a decline of an additional 0.
Based on these findings, older patients who already have some degree of cognitive impairment would be considered most vulnerable to anticholinergic agents. In advanced age, the central nervous system is very sensitive to adverse anticholinergic effects due to the significant decrease in cholinergic neurons or receptors in the brain, the reduction in hepatic metabolism and renal excretion of medications, and the increase in blood—brain barrier permeability.
One unique and rather unanticipated aspect of the study is the link between mortality and anticholinergic burden. As with cognitive impairment, the association between the use of anticholinergic medication and death at 2 years was an observed dose-response effect involving the ACB score. Moreover, the effect was present for the use of definite as well as possible anticholinergics, and results did not vary according to baseline MMSE scores.
In speculating on the reasons for the substantial increased risk of death observed among anticholinergic users, researchers appeared dissuaded from the idea that the studied population might have just been older or sicker at baseline.
Data were adjusted for age, sex, baseline MMSE score, education, social class, number of nonanticholinergic medications, and number of health conditions. Although the lead author implicated the toll of anticholinergic agents on the cardiovascular and other major organ systems as a suspected reason for the increased risk of death, a cause-and-effect relationship has not been established.
In fact, researchers remain uncertain about the validity of the findings because medications with possible anticholinergic effects are used for many diseases eg, hypertension, congestive heart failure ; therefore, the results may, after all, reflect the prevalence of anticholinergic prescribing in disease states with significant morbidity. Delirium was frequently identified by disorientation, altered consciousness, disorganized thinking, and fluctuating alertness.
In applying the significance of these observations to the clinical setting, many practitioners rely on global measures to evaluate cognitive performance and, therefore, may not accurately identify a decline in cognitive function when evaluating exposure to anticholinergics. As previously mentioned, first-generation antihistamines are more easily identified as anticholinergic offenders, but other agents with anticholinergic properties such as digoxin, warfarin, prednisone, and codeine are unlikely to set off alarms among prescribers, or perhaps even among pharmacists.
Consumers may be better prepared to assess their own risk, given articles in the lay press, including the editorial in The New York Times, that refer them to the ACB scale.
Rabin RC. Cocktail of popular drugs may cloud brain. Accessed February 29, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. Tune LE. Anticholinergic effects of medications in elderly patients. J Clin Psychiatry. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.
J Clin Pharmacol. Reinber S. Some OTC sleep, cold meds could harm aging brain. Accessed March 6, The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. United States Census Bureau. Published May 10, Accessed February 10, The anticholinergic burden scale.
The Anticholinergic Cognitive Burden. April 9, Elena Beyzarov, PharmD. Adapted from reference 8. References 1. Challenge Owners to Define Support Staff.
localhost › /02/27 › cocktail-of-popular-drugs-may-clo. Corticosteroids are often used in combination with beta2-agonist and anticholinergic bronchodilators in the treatment of chronic obstructive pulmonary. Corticosteroids are often used in combination with β2-agonist and anticholinergic bronchodilators in the treatment of chronic obstructive. Corticosteroids are often used in combination with beta2-agonist and anticholinergic bronchodilators in the treatment of chronic obstructive pulmonary. Anticholinergic drugs block (antagonize) the action of the neurotransmitter acetylcholine. A neurotransmitter is a chemical released by nerve. Called anticholinergics, the drugs block the action of the neurotransmitter acetylcholine, sometimes as a direct action, but often as a side effect. The anticholinergic burden scale. Based on these findings, older patients who already have some degree of cognitive impairment would be considered most vulnerable to anticholinergic agents. Now a spate of new research studies has focused on anticholinergic medicines. Fox said. Data were adjusted for age, sex, baseline MMSE score, education, social class, number of nonanticholinergic medications, and number of health conditions. The Anticholinergic Cognitive Burden.Many people are unaware that dozens of painkillers, antihistamines and psychiatric medications — from drugstore staples to popular antidepressants — can adversely affect brain function, mostly in the elderly. Regular use of multiple medications that have this effect has been linked to cognitive impairment and memory loss. Called anticholinergics, the drugs block the action of the neurotransmitter acetylcholine, sometimes as a direct action, but often as a side effect.
Acetylcholine is a chemical messenger with a range of functions in the body, memory production and cognitive function among them. The difficulty for patients is that the effect of anticholinergic drugs is cumulative. Doctors are not always aware of all of the medications their patients take, and they do not always think to review the anticholinergic properties of the ones they prescribe. Now a spate of new research studies has focused on anticholinergic medicines.
After following more than 13, British men and women 65 or older for two years, researchers found that those taking more than one anticholinergic drug scored lower on tests of cognitive function than those who were not using any such drugs, and that the death rate for the heavy users during the course of the study was 68 percent higher. Malaz A. We adjusted for everything we could, and that signal did not go away.
Anticholinergics have also been implicated in the delirium that intensive-care patients frequently develop in the hospital. Wesley Ely, a professor of medicine at Vanderbilt University who studies neuropsychological deficits that occur after intensive care hospitalization. Of the 36 million Americans 65 and older, at least 20 percent take at least one anticholinergic medication.
A study by Dr. Boustani of nearly 4, older adults in Indianapolis found that those who had been using three or more possibly anticholinergic drugs consistently for 90 days or longer were nearly three times as likely to receive a diagnosis of mild cognitive impairment as those who had not taken anticholinergics.
Boustani said. No association was found between chronic use of anticholinergics and dementia, however, even though mild cognitive impairment often precedes dementia. Boustani said the reasons for this were not clear. The aim of studies like these is to evaluate the magnitude of the effects of different drugs, to determine whether there are safe thresholds for their use and to learn whether the effect is transient and reversible.
Still, there is already a consensus in the scientific community that anticholinergic compounds should be prescribed with caution, especially for the elderly. Still, Dr. Even so, why do physicians prescribe any medications with anticholinergic activity to elderly people, who may be using them regularly for many years? Not only are doctors often unaware of all the medicines their patients are taking, but the list of drugs with anticholinergic properties is a long one. The heart drug digoxin, the blood thinner warfarin, the painkiller codeine and prednisone are considered mild anticholinergics.
Those with the most severe effects include Paxil, Benadryl, a drug for overactive bladder called oxybutynin, and the schizophrenia drug clozapine. Fox said. If you or an elderly relative take one or more drugs on a regular basis, ask your primary care physician to evaluate the cumulative anticholinergic burden of all them as well as other potential interactions and side effects.
Thies said. Remember to tell your physician about drugs prescribed by other specialists, as well as nonprescription or alternative medicines you take. He or she should be able to prescribe substitutes without anticholinergic effects. This review should be done once a year. Do not stop medications on your own without medical supervision. Even before going to the doctor, do your own research.
Use the Anticholinergic Burden scale , developed by scientists from the Regenstrief Institute, to assess your risk. The scale ranks drugs based on the strength of their anticholinergic activity, from zero if there is no effect to 3 for severe effect.
Keep in mind that many over-the-counter drugs, including allergy medications, antihistamines and Tylenol PM, have anticholinergic effects. Boustani advised. There may be no adequate substitutes for some essential anticholinergic drugs. In that case, Dr. See next articles. Tim Robinson. The Consumer Articles on how medicine affects both your well-being and your wallet. Reach the Preschool Set.
Comments
Post a Comment